Melissa K Andrew1, Kenneth Rockwood. 1. Division of Geriatric Medicine, Dalhousie University & QEII Health Sciences Centre, Suite 1421, CHVMB, 5955 Veterans' Memorial Lane, Halifax, Nova Scotia, B3H 2E1, Canada.
Abstract
OBJECTIVE: To determine what change in the Modified Mini-Mental State Examination (3MS), a validated and widely used cognitive screening tool for which meaningful change scores have not been clearly characterized, should be considered meaningful. STUDY DESIGN AND SETTING: The 3MS was administered at baseline after 5 and 10 years, as part of the population-based Canadian Study of Health and Aging. We calculated Cohen's effect sizes to estimate detectable changes in 3MS screening scores over 5 and 10 years in this large and representative study sample. RESULTS: A total of 3,255 older adults who were community dwelling at baseline completed the 3MS as part of a screening interview at all three interviews. Mean 3MS score was 90.4 (standard deviation [SD] 6.9) at t(1), 89.1 (SD 8.2) at 5 years, and 85.8 (SD 13.0) at 10 years. A change of just over one point, over 5 and 10 years, represented a clinically detectable change with a medium effect size (Cohen's d=0.5). CONCLUSIONS: Although a change of >or=1 point was clinically detectable, consideration of additional criteria for clinical meaningfulness suggested that a change of >or=5 points likely represents a clinically meaningful difference for groups, and is a reasonable choice of cutoff in studies using the 3MS to define cognitive change in individuals.
OBJECTIVE: To determine what change in the Modified Mini-Mental State Examination (3MS), a validated and widely used cognitive screening tool for which meaningful change scores have not been clearly characterized, should be considered meaningful. STUDY DESIGN AND SETTING: The 3MS was administered at baseline after 5 and 10 years, as part of the population-based Canadian Study of Health and Aging. We calculated Cohen's effect sizes to estimate detectable changes in 3MS screening scores over 5 and 10 years in this large and representative study sample. RESULTS: A total of 3,255 older adults who were community dwelling at baseline completed the 3MS as part of a screening interview at all three interviews. Mean 3MS score was 90.4 (standard deviation [SD] 6.9) at t(1), 89.1 (SD 8.2) at 5 years, and 85.8 (SD 13.0) at 10 years. A change of just over one point, over 5 and 10 years, represented a clinically detectable change with a medium effect size (Cohen's d=0.5). CONCLUSIONS: Although a change of >or=1 point was clinically detectable, consideration of additional criteria for clinical meaningfulness suggested that a change of >or=5 points likely represents a clinically meaningful difference for groups, and is a reasonable choice of cutoff in studies using the 3MS to define cognitive change in individuals.
Authors: Ahmed M Kassem; Mary Ganguli; Kristine Yaffe; Joseph T Hanlon; Oscar L Lopez; John W Wilson; Jane A Cauley Journal: Int Psychogeriatr Date: 2017-04-09 Impact factor: 3.878
Authors: Lissette M Piedra; Flavia C D Andrade; Rosalba Hernandez; Seth William Boughton; Laura Trejo; Catherine A Sarkisian Journal: Gerontologist Date: 2017-11-10
Authors: Nora L Watson; Kim Sutton-Tyrrell; Caterina Rosano; Robert M Boudreau; Susan E Hardy; Eleanor M Simonsick; Samer S Najjar; Lenore J Launer; Kristine Yaffe; Hal H Atkinson; Suzanne Satterfield; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2011-07-18 Impact factor: 6.053
Authors: N L Watson; C Rosano; R M Boudreau; E M Simonsick; L Ferrucci; K Sutton-Tyrrell; S E Hardy; H H Atkinson; K Yaffe; S Satterfield; T B Harris; A B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2010-06-25 Impact factor: 6.053
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: J Neurol Sci Date: 2014-02-18 Impact factor: 3.181
Authors: Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer Journal: Arch Neurol Date: 2009-11
Authors: Ruth Peters; Nigel Beckett; Robert Beardmore; Rafael Peña-Miller; Kenneth Rockwood; Arnold Mitnitski; Shahrul Mt-Isa; Christopher Bulpitt Journal: PLoS One Date: 2010-07-26 Impact factor: 3.240